Benjamin Clayton Lecture - "Understanding Tyrosine Kinases to Define New Therapeutic Opportunities"

Mark Lemmon
Event starts on this day




Event starts at this time 4:00 pm – 5:00 pm
In Person (view details)
Featured Speaker(s): Dr. Mark Lemmon
Clayton Named Lecture


The Molecular Biosciences Department welcomes Dr. Mark Lemmon for the Benjamin Clayton Named Lecture.  

Mark Lemmon, PhD, FRS is the Alfred Gilman Professor of Pharmacology, and Co-Director of Yale Cancer Biology Institute.  Dr. Lemmon was elected as a Fellow of the Royal Society (the UK's national academy) in 2016, and has been honored with the Dorothy Crowfoot Hodgkin Award of the Protein Society and the Stanley N. Cohen Biomedical Research Award from the University of Pennsylvania. He is on the Editorial Advisory Boards of several journals, including Cell and Molecular Cell, and is Chair of the Editorial Board of the Biochemical Journal.

Dr. Lemmon's seminar, "Understanding Tyrosine Kinases to Define New Therapeutic Opportunities" will be held on Monday, April 15 at 4:00 PM in POB 2.302 with a reception to follow at 5:00 PM.

Click here to learn more about Dr. Lemmon's research.


POB 2.302


Other Events in This Series